Table of Contents
In a latest study, scientists aimed to discover how considerably of the antidepressant investigate literature is legitimate and how significantly is “hijacked for marketing and advertising reasons.” They looked at the largest, most influential medical trials of antidepressants and uncovered that nearly half ended up so biased that they could be viewed as “seeding trials”—or scientific tests that deliver marketing and advertising materials for the pharmaceutical sector, not valid scientific facts.
“Large trials are rare in the field of antidepressant research. In the couple of existing trials, vital results this sort of as suicidality and the functional affect of mental diseases were being very little studied. A sizeable proportion of these trials could be internet marketing trials (‘seeding trials’),” the scientists produce.
The analyze, led by Samuel Martineau at the University of Rennes, France, was published in BMJ Open up. The researchers also bundled Florian Naudet and Ioana-Alina Cristea, who have co-authored past research on how pharma undermines drug regulators in numerous ways as perfectly as how medical journals make biased publication decisions.

